Frontier IP Group (âFrontier IPâ) provides equity-based marketing services to private technology companies through four high-growth technology clusters including: artificial intelligence, robotics, and big and sparse data; pathogens and cell imaging; food and agrotech; and artificial particles and materials.
(): Full year results
Creating value for growth technology companies
Frontier IP Group (âFrontier IPâ) provides equity-based marketing services to private technology companies through four high growth technology clusters including: artificial intelligence, robotics and big and sparse data; pathogens and cell imaging; food and agrotech; and artificial particles and materials. Frontier IP’s early access to companies with cutting edge intellectual property and the structural growth of target clusters offer significant upside potential. The year ending June 2021 saw the value of Frontier IP’s portfolio increase by 64% to Â£ 32.0million (from a 47% increase to Â£ 19.4million in the year 2020).
Access to the advanced university IP
The Group has worked with universities such as Cambridge, Heriot Watt Manchester, Plymouth and NOVA University Lisbon. Frontier IP’s relationships help ensure quick access to cutting-edge intellectual property, such as AI in a drug discovery that led to a 1.7% stake in UK-based Exscientia (NASDAQ EXAI). Its AI is now deployed to help discover drugs for pharmaceutical majors including Bayer, Bristol-Myers Squibb, GlaxoSmithKline, Roche and Sanofi. As of October 2021, Exscientia is listed on the Nasdaq, raising $ 465 million. Frontier IP’s stake in Exscientia has now reached a value of Â£ 29.3million, with this growth contributing significantly to the overall increase in Frontier IP’s portfolio in fiscal 2021.
Strong relationships with industry partners
Frontier IP works closely with universities, research institutes and academics to identify intellectual property that can be commercialized. The Group therefore plays a leading role not only by providing expertise and access to external financing, but also in marketing by adopting a practical approach to commercial and technical development and by calling on industrial partners. This is the key to increasing the value of equity. For this, it secures participations and fees. Industry partners include Bosch, which Frontier introduced to portfolio companies Fieldwork Robotics and Pulsiv Solar.
Exscientia clearly demonstrates the strength of the Frontier IP model. The portfolio also includes a number of other companies in a phase of accelerating their commercial development. This paves the way for an increase in valuation or a potential exit. We believe that Frontier IP represents an excellent opportunity for investors to gain exposure to early stage technology companies, based on cutting edge intellectual property, which meet the needs and demands of international markets and although it has almost doubled. since our inception, we continue to see potential for further earnings.
We reiterate our purchase recommendation.
Phil Smith, Chief Technology Officer | T: +44 (0) 20 3617 5187 | E: [email protected]
Limited, New Liverpool House, 15-17 Eldon Street, London EC2M 7LD | www.vsacapital.com
This email is intended for the designated recipient only. It may contain privileged and / or confidential information. If you are not one of the intended recipients, please notify the sender immediately and destroy this email: any disclosure, copying to any person or any action taken or omitted based on this email is prohibited and may be illicit. All opinions expressed in this message are those of the individual sender, except where specifically stated to be the opinion of VSA Capital Limited, its subsidiaries or associates. While every effort is made to protect incoming and outgoing email messages, VSA Capital Limited and its subsidiaries or associates cannot guarantee that attachments are virus-free or compatible with your systems and do not accept any responsibility for viruses. or computer problems encountered.
VSA Capital Limited will use your personal information to administer your account in order to provide any products and services that you have requested from us. Your personal information will be kept secure and will not be shared with any other party unless you give your consent to do so.
VSA Capital Limited is authorized and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange.
The Company is registered in England under number 2405923 at New Liverpool House, 15-17 Eldon Street, London EC2M 7LD.